366 related articles for article (PubMed ID: 15262415)
21. Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evaluation in vitro.
Matsumoto J; Nakada Y; Sakurai K; Nakamura T; Takahashi Y
Int J Pharm; 1999 Aug; 185(1):93-101. PubMed ID: 10425369
[TBL] [Abstract][Full Text] [Related]
22. Production of insulin-loaded poly(ethylene glycol)/poly(l-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques.
Elvassore N; Bertucco A; Caliceti P
J Pharm Sci; 2001 Oct; 90(10):1628-36. PubMed ID: 11745721
[TBL] [Abstract][Full Text] [Related]
23. Development of PEG-PLA/PLGA microparticles for pulmonary drug delivery prepared by a novel emulsification technique assisted with amphiphilic block copolymers.
Takami T; Murakami Y
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):433-8. PubMed ID: 21715147
[TBL] [Abstract][Full Text] [Related]
24. Folate-conjugated amphiphilic star-shaped block copolymers as targeted nanocarriers.
Zhu J; Zhou Z; Yang C; Kong D; Wan Y; Wang Z
J Biomed Mater Res A; 2011 Jun; 97(4):498-508. PubMed ID: 21509931
[TBL] [Abstract][Full Text] [Related]
25. In-situ formation of biodegradable hydrogels by stereocomplexation of PEG-(PLLA)8 and PEG-(PDLA)8 star block copolymers.
Hiemstra C; Zhong Z; Li L; Dijkstra PJ; Feijen J
Biomacromolecules; 2006 Oct; 7(10):2790-5. PubMed ID: 17025354
[TBL] [Abstract][Full Text] [Related]
26. Effect of the Polymer Architecture on the Structural and Biophysical Properties of PEG-PLA Nanoparticles.
Rabanel JM; Faivre J; Tehrani SF; Lalloz A; Hildgen P; Banquy X
ACS Appl Mater Interfaces; 2015 May; 7(19):10374-85. PubMed ID: 25909493
[TBL] [Abstract][Full Text] [Related]
27. Preparation of biodegradable nanoparticles of tri-block PLA-PEG-PLA copolymer and determination of factors controlling the particle size using artificial neural network.
Asadi H; Rostamizadeh K; Salari D; Hamidi M
J Microencapsul; 2011; 28(5):406-16. PubMed ID: 21736525
[TBL] [Abstract][Full Text] [Related]
28. Nanoparticles of poly(D,L-lactide)/methoxy poly(ethylene glycol)-poly(D,L-lactide) blends for controlled release of paclitaxel.
Dong Y; Feng SS
J Biomed Mater Res A; 2006 Jul; 78(1):12-9. PubMed ID: 16596586
[TBL] [Abstract][Full Text] [Related]
29. PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease.
Lautenschläger C; Schmidt C; Lehr CM; Fischer D; Stallmach A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):578-86. PubMed ID: 24084650
[TBL] [Abstract][Full Text] [Related]
30. Effect of aqueous solubility of grafted moiety on the physicochemical properties of poly(d,l-lactide) (PLA) based nanoparticles.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2010 Mar; 388(1-2):263-73. PubMed ID: 20060450
[TBL] [Abstract][Full Text] [Related]
31. Influence of PEGylation on nanoparticle mobility in different models of the extracellular matrix.
Tomasetti L; Liebl R; Wastl DS; Breunig M
Eur J Pharm Biopharm; 2016 Nov; 108():145-155. PubMed ID: 27544052
[TBL] [Abstract][Full Text] [Related]
32. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
Sant S; Poulin S; Hildgen P
J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
[TBL] [Abstract][Full Text] [Related]
33. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.
Gref R; Lück M; Quellec P; Marchand M; Dellacherie E; Harnisch S; Blunk T; Müller RH
Colloids Surf B Biointerfaces; 2000 Oct; 18(3-4):301-313. PubMed ID: 10915952
[TBL] [Abstract][Full Text] [Related]
34. Preparation and evaluation of biodegradable microspheres containing a new potent osteogenic compound and new synthetic polymers for sustained release.
Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
Int J Pharm; 2010 Jun; 392(1-2):42-50. PubMed ID: 20227474
[TBL] [Abstract][Full Text] [Related]
35. [Characterization of Me. PEG-PLA copolymer nanoparticles prepared by modified spontaneous emulsion-solvent evaporation].
Dong J; Liu MX; Yang YJ; Xu HB; Yang XL
Yao Xue Xue Bao; 2004 Sep; 39(9):677-80. PubMed ID: 15606012
[TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of fenofibrate-loaded PLA-PEG microspheres.
Ren J; Yu X; Ren T; Hong H
J Mater Sci Mater Med; 2007 Aug; 18(8):1481-7. PubMed ID: 17387589
[TBL] [Abstract][Full Text] [Related]
37. Preparation of a PLA-PEG block copolymer using a PLA derivative with a formyl terminal group and its application to nanoparticulate formulation.
Sasatsu M; Onishi H; Machida Y
Int J Pharm; 2005 Apr; 294(1-2):233-45. PubMed ID: 15814247
[TBL] [Abstract][Full Text] [Related]
38. Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel.
Ruan G; Feng SS
Biomaterials; 2003 Dec; 24(27):5037-44. PubMed ID: 14559017
[TBL] [Abstract][Full Text] [Related]
39. Influence of PLA-PEG nanoparticles manufacturing process on intestinal transporter PepT1 targeting and oxytocin transport.
Gourdon B; Chemin C; Moreau A; Arnauld T; Delbos JM; Péan JM; Declèves X
Eur J Pharm Biopharm; 2018 Aug; 129():122-133. PubMed ID: 29803721
[TBL] [Abstract][Full Text] [Related]
40. Preparation and biodisposition of methoxypolyethylene glycol amine-poly(DL-lactic acid) copolymer nanoparticles loaded with pyrene-ended poly(DL-lactic acid).
Sasatsu M; Onishi H; Machida Y
Int J Pharm; 2008 Jun; 358(1-2):271-7. PubMed ID: 18448290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
